{"id":36013,"date":"2025-02-21T13:23:11","date_gmt":"2025-02-21T07:53:11","guid":{"rendered":"https:\/\/dailynewsindia.co.in\/index.php\/2025\/02\/21\/genomics-unveiled-indias-path-to-precision-medicine\/"},"modified":"2025-02-21T13:23:11","modified_gmt":"2025-02-21T07:53:11","slug":"genomics-unveiled-indias-path-to-precision-medicine","status":"publish","type":"post","link":"https:\/\/dailynewsindia.co.in\/index.php\/2025\/02\/21\/genomics-unveiled-indias-path-to-precision-medicine\/","title":{"rendered":"Genomics Unveiled: India\u2019s Path To Precision Medicine"},"content":{"rendered":"<div>\n<p dir=\"ltr\"><strong>New Delhi [India], February 21: <\/strong>In a densely populated nation like India, delivering personalized healthcare demands extraordinary commitment. Despite the rise of specialty hospitals, only 5% of the population has access to advanced diagnostic tests, according to Statista. This stark gap is what\u00a0<a href=\"https:\/\/www.yodadiagnostics.com\/book-a-test\" target=\"_blank\" rel=\"noopener\">Yoda Diagnostics<\/a>\u00a0aims to bridge.<\/p>\n<p dir=\"ltr\"><strong>A Life-Saving Story of Genomics in Action<\/strong><\/p>\n<p dir=\"ltr\">Prof. Mridula Sharma, a retired college principal, battled a life-threatening arrhythmia unresponsive to conventional treatments. After exhausting standard medications, her cardiologist recommended genomic testing. Yoda Diagnostics\u2019 PGx\u2014Cardiovascular panel sequencing revealed a mutation in the MYH7 gene, a known cause of hereditary heart disease. This insight led to targeted therapy, stabilizing her condition and significantly improving her quality of life.<\/p>\n<p dir=\"ltr\">Had Prof. Sharma lacked access to such diagnostics, her fate could have been different. While genomics is mainstream in countries like the US, Yoda Diagnostics was founded to bring this transformative power to India and democratize genomic healthcare.<\/p>\n<p dir=\"ltr\"><strong>The State of Genomics in India<\/strong><\/p>\n<p dir=\"ltr\">Since the first human genome was sequenced in 2003, costs and time have plummeted. Today, sequencing can be completed in a day at a fraction of its original cost. Yet, precision medicine in India remains underutilized due to cost barriers, limited infrastructure, and regulatory constraints.<\/p>\n<p dir=\"ltr\">\u201cPrecision medicine is not a futuristic ideal; it\u2019s a present-day necessity,\u201d asserts Dr. Shaik Mohammed Naushad, Chief Scientific Officer at Yoda Diagnostics. The company offers a range of testing panels\u2014from oncology to rare disease diagnostics\u2014tailored for Indian patients. However, limited insurance coverage means the financial burden often falls on patients, making these life-saving advancements inaccessible for many.<\/p>\n<p dir=\"ltr\"><strong>Bridging the Gap: Yoda Diagnostics\u2019 Commitment to Accessible Genomics<\/strong><\/p>\n<p dir=\"ltr\">Despite the global genetic testing market surpassing $17 billion, India\u2019s share remains modest at around $60 million. Yoda Diagnostics aims to change this by delivering precise, affordable, and globally benchmarked genetic testing solutions.<\/p>\n<p dir=\"ltr\">Establishing a state-of-the-art genomic lab in Hyderabad was no small feat. Founder Sudhakar Kancharla, inspired by American diagnostic models, sought to replicate their advanced framework in India, focusing on accessibility and affordability.<\/p>\n<p dir=\"ltr\">\u201cFor India, we need more than technology; we need accessibility and affordability,\u201d says Kancharla, who previously established diagnostic labs and IT companies in the US. His vision extends beyond diagnostics\u2014he advocates for genomic health as a standard component of patient care.<\/p>\n<p dir=\"ltr\"><strong>Leading the Charge: Innovation, Quality, and Patient Care<\/strong><\/p>\n<p dir=\"ltr\">Yoda Diagnostics specializes in oncology panels, cardiovascular diagnostics, and rare disease panels. The company collaborates closely with clinicians to deliver precise, actionable results, adhering to global accreditation standards like NABL and ICMR. Their proprietary tools, designed per ACMG guidelines, provide germline and somatic genetic analysis with unmatched precision.<\/p>\n<p dir=\"ltr\"><strong>Founder\u2019s Vision: A Personal Journey to Precision Medicine<\/strong><\/p>\n<p dir=\"ltr\">Sudhakar Kancharla\u2019s journey is both inspiring and personal. Born and raised in India, he pursued molecular biology in the US, working at top healthcare institutions. His expertise in molecular genetics and genomics in oncology and rare diseases motivated him to return to India to make precision medicine accessible.<\/p>\n<p dir=\"ltr\">\u201cWe saw the power of genomics in transforming patient care and wanted to bring it to the average Indian patient,\u201d Kancharla shares. Yoda Diagnostics embodies this commitment through education initiatives, collaborations with hospitals, and awareness programs.<\/p>\n<p dir=\"ltr\"><strong>Building India\u2019s Genomic Database: A Pioneering Initiative<\/strong><\/p>\n<p dir=\"ltr\">For genomics to reach its full potential, building a comprehensive genetic database is crucial. Precision medicine relies on identifying genetic variations across populations, yet most global genomic databases are skewed toward Western populations, leaving India\u2019s genetic diversity largely unexplored.<\/p>\n<p dir=\"ltr\">Yoda Diagnostics is addressing this gap by partnering with researchers to construct a robust Indian genomic database. This initiative aims to enhance patient care and advance research, particularly for conditions prevalent in South Asian communities.<\/p>\n<p dir=\"ltr\"><strong>The Road Ahead: Paving the Way for India\u2019s Genomic Revolution<\/strong><\/p>\n<p dir=\"ltr\">Mainstreaming precision medicine in India faces challenges\u2014regulatory hurdles, data privacy concerns, and affordability. Yet, with the push for a national digital health ecosystem and genomic initiatives by Yoda Diagnostics, the future looks promising.<\/p>\n<p dir=\"ltr\">\u201cOur vision is to make genomic testing as routine as an MRI or blood test,\u201d Kancharla affirms. By merging international expertise with a commitment to Indian healthcare, Yoda Diagnostics is paving the way for a genomics-driven future. As awareness grows, India\u2019s genomic revolution is not a distant dream\u2014it\u2019s on the horizon.<\/p>\n<p dir=\"ltr\">This is not just healthcare innovation; it\u2019s a movement to empower every Indian with the knowledge and resources they need to take control of their health\u2014one genome at a time.<\/p>\n<p dir=\"ltr\"><em>If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New Delhi [India], February 21: In a densely populated nation like India, delivering personalized healthcare demands extraordinary commitment. Despite the rise of specialty hospitals, only 5% of the population has access to advanced diagnostic tests, according to Statista. This stark gap is what\u00a0Yoda Diagnostics\u00a0aims to bridge. A Life-Saving Story of Genomics in Action Prof. Mridula&#8230;<\/p>\n<p class=\"more-link-wrap\"><a href=\"https:\/\/dailynewsindia.co.in\/index.php\/2025\/02\/21\/genomics-unveiled-indias-path-to-precision-medicine\/\" class=\"more-link\">Read More<span class=\"screen-reader-text\"> &ldquo;Genomics Unveiled: India\u2019s Path To Precision Medicine&rdquo;<\/span> &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":36014,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[639],"class_list":["post-36013","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-health"],"_links":{"self":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/36013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/comments?post=36013"}],"version-history":[{"count":0,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/36013\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media\/36014"}],"wp:attachment":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media?parent=36013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/categories?post=36013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/tags?post=36013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}